AbbVie submits applications for treatment of chronic disease
February 14, 2022Sales and Marketing
AbbVie has announced the submission of applications seeking the approval of upadacitinib, (RINVOQ®, 15 mg once daily) for the treatment …
Gilead’s HIV treatment demonstrates high efficacy and viral suppression at five years
February 14, 2022Sales and Marketing
Gilead Sciences has announced the presentation of cumulative five-year results from two Phase III studies of Biktarvy. The new, long-term …
First UK Lassa fever death in over a decade
February 14, 2022Sales and Marketing
A patient in Bedfordshire has died from a confirmed case of Lassa fever, the UK Health Security Agency (UKHSA) has …
Risk of new heart problems raised after COVID-19
February 11, 2022Medical Communications
A large study has found that long after recovery from COVID-19, people continue to face significantly higher risks for new …
Novavax COVID-19 vaccine meets trial endpoints
February 11, 2022Medical Communications
Novavax has announced that NVX-CoV2373, its recombinant nanoparticle protein-based COVID-19 vaccine, achieved its primary effectiveness endpoint in the paediatric expansion …
Sickest patients face record long waits for hospital bed
February 11, 2022Medical Communications
According to NHS data, the sickest patients are facing record long waits for a bed upon admission to hospital in …
Researchers find molecular treatment works against metastatic cancer spread to the brain
February 11, 2022Medical Communications
According to a study published in Clinical Cancer Research, scientists at Mount Sinai conducting clinical trials of a drug targeting …
First biologic medicine approved in China for lupus
February 10, 2022Business Services
Nearly half a million people in China have systematic lupus erythematosus (SLE), and more than have of this number will …
COVID-19 isolation law could end this month in England
February 10, 2022Business Services
Boris Johnson has said that all remaining COVID-19 restrictions in England – including the legal rule to self-isolate – could …
AI support tool aims to change skin cancer treatment in the NHS
February 10, 2022Business Services
Chelsea and Westminster Hospital NHS Foundation Trust has announced the expansion of its partnership with Skin Analytics, with the roll …
FDA accepts Dupixent (dupilumab) for children with moderate-to-severe atopic dermatitis
February 10, 2022Business Services
The FDA has accepted the supplemental Biologics License Application (sBLA) for Dupixent (dupilumab) for children aged six months to five …
FDA investigate possible increased risk of death with lymphoma medicine
February 9, 2022Research and Development
The FDA is investigating a possible increased risk of death with the cancer medicine Ukoniq (umbralisib). The administration is continuing …
SaNOtize breakthrough treatment 99% effective against COVID-19
February 9, 2022Research and Development
SaNOtize and Glenmark Pharmaceuticals Limited have announced successful results of their Phase III clinical trials, as well as the approval …
Despite persistent need, J&J halts COVID-19 vaccine output
February 9, 2022Research and Development
Johnson & Johnson has temporarily suspended production at a key plant manufacturing the COVID-19 vaccine. The easily administered vaccine is …
NHS waiting-list backlog will take years to clear, ministers say
February 9, 2022Ministers say that the waiting list for hospital treatment will not start falling for two years, in spite of unveiling …
Thermo Fisher Scientific partners with Medidata Acorn AI for clinical research advancement
February 8, 2022Manufacturing and Production
Thermo Fisher Scientific has announced a multiyear partnership with medidata Acorn AI, a Dassault Systemes company leading the digital transformation …
Thousands with advanced prostate cancer to benefit from drug approval
February 8, 2022Manufacturing and Production
Astellas has announced that the SMC has accepted the use of XTANDIâ„¢ (enzalutamide) to treat patients with metastatic hormone-sensitive prostate …
SMC approves diroximel fumarate as multiple sclerosis treatment
February 8, 2022Manufacturing and Production
The SMC has approved VUMERITY (diroximel fumarate), a next-generation oral fumarate for the treatment of adults living with relapsing-remitting multiple …
First immunotherapy to treat advanced endometrial cancer on the NHS via Cancer Drugs Fund
February 8, 2022Manufacturing and Production
GSK has shared that NICE is to issue a final appraisal determination (FAD) recommending the use of JEMPERLI®▼ (dostarlimab) via …
First gene therapy for rare genetic neurodegenerative disorder in children
February 7, 2022Sales and Marketing
NICE has published a draft highly specialised technologies guidance, recommending gene therapy atidarsagene autotemcel for some children with the rare, …
Latest content
